<DOC>
	<DOCNO>NCT00383539</DOCNO>
	<brief_summary>The primary objective trial demonstrate equivalence , term immunogenicity , three different industrial lot investigational vaccine thereby support consistency manufacturing process . Secondary Objectives : Immunogenicity To demonstrate investigational vaccine induces immune response least good one induced reference vaccine , term antibody titer . To assess immunogenicity investigational vaccine use parameter define European Medicines Agency ( EMEA ) Note Guidance ( CPMP/BWP/214/96 ) . Safety : To demonstrate investigational vaccine least well tolerated reference vaccine , term define safety profile . To describe safety profile vaccination . Comfort vaccination assessment : To assess pain immediately injection use Verbal Rating Scale . To describe vaccination comfort injection use -Patient-Reported Outcome questionnaire : Vaccination Comfort Questionnaire .</brief_summary>
	<brief_title>Lot-to-Lot Consistency Study Investigational , Inactivated , Split-Virion Influenza Vaccine Adults</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged 18 60 year day inclusion . Informed consent form sign . Able attend schedule visit comply trial procedure . For woman , inability bear child negative urine pregnancy test first visit . Exclusion Criteria : Systemic hypersensitivity egg protein , chick protein , vaccine component , particular , neomycin , formaldehyde , octoxinol 9 , history lifethreatening reaction trial vaccine vaccine contain substance . Febrile illness ( oral temperature &gt; = 37.5°C , rectal equivalent temperature &gt; = 38.0°C ) day inclusion . Participation another clinical trial 4 week precede trial vaccination . Planned participation another clinical trial present trial period . Congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy . Unstable chronic illness ( defined illness require hospitalization clinically significant change medication 12 week prior inclusion ) stage could interfere trial conduct completion . Current abuse alcohol drug addiction may interfere subject 's ability comply trial procedure . Blood bloodderived product receive past 3 month . Any vaccination 4 week precede trial vaccination . Vaccination plan 4 week follow trial vaccination . Previous vaccination influenza ( previous 6 month ) . Thrombocytopenia bleed disorder contraindicate intramuscular vaccination . Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviruses</keyword>
	<keyword>Inactivated Split-virion influenza vaccine</keyword>
	<keyword>Adults</keyword>
</DOC>